Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.35+0.10 (+1.21%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Bausch Health Companies operating margin
Operating margin is operating income as a percentage of revenue.
Bausch Health Companies's operating margin for the twelve months ending Sep 30, 2026 was 11.2%. For fiscal 2025 it was 17.7%, against 16.1% the year before. The highest annual figure on record is 24.4% in fiscal 2014.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17.7% | +1.6 |
| FY2024 | Dec 31, 2024 | 16.1% | +5.1 |
| FY2023 | Dec 31, 2023 | 11.0% | +5.4 |
| FY2022 | Dec 31, 2022 | 5.6% | +0.3 |
| FY2021 | Dec 31, 2021 | 5.3% | −3.1 |
| FY2020 | Dec 31, 2020 | 8.4% | +10.8 |
| FY2019 | Dec 31, 2019 | -2.4% | +26.1 |
| FY2018 | Dec 31, 2018 | -28.4% | −29.6 |
| FY2017 | Dec 31, 2017 | 1.2% | +7.0 |
| FY2016 | Dec 31, 2016 | -5.9% | −20.5 |
| FY2015 | Dec 31, 2015 | 14.6% | −9.8 |
| FY2014 | Dec 31, 2014 | 24.4% | +31.5 |
| FY2013 | Dec 31, 2013 | -7.1% | −9.4 |
| FY2012 | Dec 31, 2012 | 2.3% | −10.1 |
| FY2011 | Dec 31, 2011 | 12.4% | +21.7 |
| FY2010 | Dec 31, 2010 | -9.3% | −31.4 |
| FY2009 | Dec 31, 2009 | 22.1% | +5.7 |
| FY2008 | Dec 31, 2008 | 16.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 33.4% | +10.3 |
| Q2 FY2026 | Jun 30, 2026 | 25.9% | +8.4 |
| Q1 FY2026 | Mar 31, 2026 | -37.6% | −49.9 |
| Q4 FY2025 | Dec 31, 2025 | 17.0% | −4.9 |
| Q3 FY2025 | Sep 30, 2025 | 23.1% | +10.4 |
| Q2 FY2025 | Jun 30, 2025 | 17.5% | +1.4 |
| Q1 FY2025 | Mar 31, 2025 | 12.2% | −0.8 |
| Q4 FY2024 | Dec 31, 2024 | 21.8% | +6.8 |
| Q3 FY2024 | Sep 30, 2024 | 12.7% | +12.0 |
| Q2 FY2024 | Jun 30, 2024 | 16.2% | −2.8 |
| Q1 FY2024 | Mar 31, 2024 | 13.1% | +4.0 |
| Q4 FY2023 | Dec 31, 2023 | 15.0% | +25.8 |
| Q3 FY2023 | Sep 30, 2023 | 0.6% | −11.3 |
| Q2 FY2023 | Jun 30, 2023 | 19.0% | +10.8 |
| Q1 FY2023 | Mar 31, 2023 | 9.0% | −5.9 |
| Q4 FY2022 | Dec 31, 2022 | -10.8% | −27.5 |
| Q3 FY2022 | Sep 30, 2022 | 11.9% | −15.3 |
| Q2 FY2022 | Jun 30, 2022 | 8.2% | +21.0 |
| Q1 FY2022 | Mar 31, 2022 | 14.9% | +25.8 |
| Q4 FY2021 | Dec 31, 2021 | 16.7% | +16.9 |
| Q3 FY2021 | Sep 30, 2021 | 27.2% | +5.7 |
| Q2 FY2021 | Jun 30, 2021 | -12.9% | −11.2 |
| Q1 FY2021 | Mar 31, 2021 | -10.9% | −23.2 |
| Q4 FY2020 | Dec 31, 2020 | -0.2% | +48.2 |
| Q3 FY2020 | Sep 30, 2020 | 21.5% | +6.6 |
| Q2 FY2020 | Jun 30, 2020 | -1.6% | −13.6 |
| Q1 FY2020 | Mar 31, 2020 | 12.3% | −1.9 |
| Q4 FY2019 | Dec 31, 2019 | -48.4% | −49.6 |
| Q3 FY2019 | Sep 30, 2019 | 14.9% | +9.4 |
| Q2 FY2019 | Jun 30, 2019 | 11.9% | +23.5 |
| Q1 FY2019 | Mar 31, 2019 | 14.2% | +128.6 |
| Q4 FY2018 | Dec 31, 2018 | 1.2% | +16.1 |
| Q3 FY2018 | Sep 30, 2018 | 5.5% | +3.8 |
| Q2 FY2018 | Jun 30, 2018 | -11.5% | −19.4 |
| Q1 FY2018 | Mar 31, 2018 | -114.3% | −124.3 |
| Q4 FY2017 | Dec 31, 2017 | -14.9% | −21.1 |
| Q3 FY2017 | Sep 30, 2017 | 1.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 7.8% | – |
| Q1 FY2017 | Mar 31, 2017 | 10.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 6.2% | – |
See a number that looks wrong?